Literature DB >> 4420796

Further studies on the interaction between anthralin salicylic acid and zinc oxide in pastes.

M Ponec-Waelsch, H J Hulsebosch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4420796     DOI: 10.1007/BF00595576

Source DB:  PubMed          Journal:  Arch Dermatol Forsch        ISSN: 0003-9187


× No keyword cloud information.
  7 in total

1.  [Dianthrones of pharmacologically important hydroxyanthraquinones].

Authors:  H AUTERHOFF; F C SCHERFF
Journal:  Arch Pharm Ber Dtsch Pharm Ges       Date:  1960-10

2.  Substitution of zinc oxide by titanium dioxide in salicylic acid pastes.

Authors:  H de VRIES
Journal:  Br J Dermatol       Date:  1961-10       Impact factor: 9.302

3.  [Effect of frangula peroxidase on frangula anthranol. IX. Report on the enzymatic & non-enzymatic oxidation of therapeutically active plant substances with 1st report on the oxidation of anthranol with peroxidase].

Authors:  G SCHENCK; H LOTH; F D FEYEN
Journal:  Arch Pharm Ber Dtsch Pharm Ges       Date:  1957-06

4.  The interaction of anthralin, salicylic acid and zinc oxide in pastes.

Authors:  H J Hulsebosch; M Ponec-Waelsch
Journal:  Dermatologica       Date:  1972

5.  [Structural characteristics of the antipsoriasic drugs chrysarobine and dithranol].

Authors:  A Krebs; H Schaltegger
Journal:  Hautarzt       Date:  1969-05       Impact factor: 0.751

6.  Factors affecting the clearance of psoriasis with dithranol (anthralin).

Authors:  S Comaish; J Smith; R H Seville
Journal:  Br J Dermatol       Date:  1971-03       Impact factor: 9.302

7.  [The behavior of hydroxydianthrone derivatives in alkaline media].

Authors:  H AUTERHOFF; R SACHDEV
Journal:  Arch Pharm Ber Dtsch Pharm Ges       Date:  1962-11
  7 in total
  2 in total

1.  Stability of anthralin in liposomal phospholipids.

Authors:  G Mahrle; B Bonnekoh; M Ghyczy; W Wiegrebe
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

Review 2.  Steroids versus nonsteroids in the treatment of cutaneous inflammation: therapeutic modalities for office use.

Authors:  E Panconesi; T Lotti
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.